Ibrahim Aldoss, MD, City of Hope National Medical Center, Duarte, CA, discusses the outcomes of allogeneic hematopoietic cell transplantation (alloHCT) in adults with Philadelphia-like (Ph-like) acute lymphoblastic leukemia (ALL). In this cohort, alloHCT was associated with a three-year survival rate of 55%; survival outcomes did not differ between Ph-like and non-Ph-like ALL. This interview took place during the Transplantation & Cellular Therapy (TCT) 2021 Meetings.